The Weighing Monotherapy Using Anticoagulant Agent and Combined Therapy Using Thrombolytic Agent in Cats with Aortic Thromboembolism

DOI JASI Web Site

Bibliographic Information

Other Title
  • 動脈血栓塞栓症猫に対する抗凝固薬の単独療法と血栓溶解薬の併用療法との比較検討
  • ドウミャク ケッセン ソクセンショウネコ ニ タイスル コウギョウコヤク ノ タンドク リョウホウ ト ケッセン ヨウカイヤク ノ ヘイヨウ リョウホウ ト ノ ヒカク ケントウ

Search this article

Description

Cats diagnosed as aortic thromboembolism were performed with monotherapy using anticoagulant agent or combined therapy using thrombolytic agent, the efficacy of those therapies were discussed. Survival time, hours of forelimb or hind limb paralysis onset, palpable or not of pressure of femoral artery (unilateral or bilateral) on the first day, the days for palpable pressure of femoral artery, and pulmonary edema or not on the first day, were discussed between each therapy group. Fifteen cats were identified as having had a prescription filled for anticoagulant therapy using low molecular weight heparins (low molecular weight heparins group: n=8) or thrombolytic therapy using tissue plasminogen activator (low molecular weight heparins group+tPA group: n=7) between 2002 and 2011. The half survival time of low molecular weight heparins group and low molecular weight heparins group+tPA group were 742 and 5 days, respectively, in low molecular weight heparins group, survival time was longer significantly than that of low molecular weight heparins group+tPA group (p<0.05).

Journal

Keywords

Details 詳細情報について

Report a problem

Back to top